These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17556800)

  • 21. [Cytotoxic and antitumor activity of a new series of heterocyclic compounds: dipyrido (4,3-b) (3,4-f) indoles].
    Chermann JC; Gruest J; Montagnier L; Wendling F; Tambourin P; Perrin M; Pochon F; Ducrocq C; Rivalle C; Bisagni E
    C R Acad Hebd Seances Acad Sci D; 1977 Oct; 285(8):945-8. PubMed ID: 410562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumoral activity of dipyrido [4,3-b] [3,4-f] indoles on L 1210 leukemia.
    Lidereau R; Chermann JC; Gruest J; Montagnier L; Ducrocq C; Rivalle C; Bisagni E
    Bull Cancer; 1980; 67(1):1-8. PubMed ID: 7362880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of cytotoxicity and cellular accumulation of polynuclear platinum complexes in L1210 murine leukemia cell lines.
    Roberts JD; Peroutka J; Beggiolin G; Manzotti C; Piazzoni L; Farrell N
    J Inorg Biochem; 1999 Oct; 77(1-2):47-50. PubMed ID: 10626353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological activity of 3- and 5-amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
    Liu MC; Lin TS; Cory JG; Cory AH; Sartorelli AC
    J Med Chem; 1996 Jun; 39(13):2586-93. PubMed ID: 8691457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic 1,3-diarylidene-2-tetralones and related compounds.
    Dimmock JR; Padmanilyam MP; Zello GA; Quail JW; Oloo EO; Prisciak JS; Kraatz HB; Cherkasov A; Lee JS; Allen TM; Santos CL; Manavathu EK; De Clercq E; Balzarini J; Stables JP
    Eur J Med Chem; 2002 Oct; 37(10):813-24. PubMed ID: 12446039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and cytotoxic activity of tetrahydropyridylidene-2- and -4-sulfonamides.
    Ho LK; Knaus EE; Allen TM; Fathi-Afshar R
    Drug Des Deliv; 1989 Jan; 4(1):35-43. PubMed ID: 2775445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological and physicochemical properties of a new anthracycline with potent antileukemic activity.
    Nafziger J; Auclair C; Florent JC; Guillosson JJ; Monneret C
    Leuk Res; 1991; 15(8):709-13. PubMed ID: 1654481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
    Liu MC; Lin TS; Sartorelli AC
    J Med Chem; 1992 Oct; 35(20):3672-7. PubMed ID: 1433178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorohydrazines of 4-oxo-4H-1-benzopyran and 1-benzopyran-2,4-dione exhibit antitumor activity against L1210 leukemia.
    Nawrot-Modranka J; Ochocki J; Graczyk J
    Pharmazie; 2004 Sep; 59(9):731-2. PubMed ID: 15497762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and cytotoxic activity of 1-alkoxy- and 1-amino-2-hydroxy-1,2-dihydroacronycine derivatives.
    Magiatis P; Mitaku S; Skaltsounis AL; Tillequin F; Koch M; Pierré A; Atassi G
    Chem Pharm Bull (Tokyo); 1999 May; 47(5):611-4. PubMed ID: 10361696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some new aryl-sydnones: effects on murine tumours.
    Grynberg N; Gomes R; Shinzato T; Echevarria A; Miller J
    Anticancer Res; 1992; 12(3):1025-8. PubMed ID: 1320354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II).
    Wilkoff LJ; Dulmadge EA; Trader MW; Harrison SD; Griswold DP
    Cancer Chemother Pharmacol; 1987; 20(2):96-100. PubMed ID: 3664938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivo.
    Jackman AL; Taylor GA; O'Connor BM; Bishop JA; Moran RG; Calvert AH
    Cancer Res; 1990 Sep; 50(17):5212-8. PubMed ID: 2386929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermodynamics and kinetics of the hydride-transfer cycles for 1-aryl-1,4-dihydronicotinamide and its 1,2-dihydroisomer.
    Zhu XQ; Cao L; Liu Y; Yang Y; Lu JY; Wang JS; Cheng JP
    Chemistry; 2003 Aug; 9(16):3937-45. PubMed ID: 12916120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The biochemical pharmacology of CI-920, a structurally novel antibiotic with antileukemic activity.
    Jackson RC; Fry DW; Boritzki TJ; Roberts BJ; Hook KE; Leopold WR
    Adv Enzyme Regul; 1985; 23():193-215. PubMed ID: 3840949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of new N-alkyl analogues of adriamycin on in vitro survival and cell cycle progression of L1210 cells.
    Traganos F; Israel M; Silber R; Seshadri R; Kirschenbaum S; Potmesil M
    Cancer Res; 1985 Dec; 45(12 Pt 1):6273-9. PubMed ID: 4063977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.
    Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Koizumi K
    Br J Cancer; 1992 Nov; 66(5):827-32. PubMed ID: 1419625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative description of morphologic changes effected by antileukemic agents in L1210 leukemia cells.
    Iwasaki H; Liu YP; Nojyo Y; Ueda T; Nakamura T
    Anticancer Res; 1995; 15(1):133-9. PubMed ID: 7733623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-function relationships for a new series of pyridine-2-carboxaldehyde thiosemicarbazones on ribonucleotide reductase activity and tumor cell growth in culture and in vivo.
    Cory JG; Cory AH; Rappa G; Lorico A; Liu MC; Lin TS; Sartorelli AC
    Adv Enzyme Regul; 1995; 35():55-68. PubMed ID: 7572354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and cytotoxic activity against L1210 leukemia of new aminocyclopenta[c]thiophenones.
    Alsaidi A; al Shargapi S; Dallemagne P; Carreiras F; Gauduchon P; Rault S; Robba M
    Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1605-8. PubMed ID: 7954912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.